Independent Financial Group LLC acquired a new position in BlackRock Science and Technology Term Trust (NASDAQ:BSTZ – Free Report) during the 1st quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 63,100 shares of the company’s stock, valued at approximately $1,398,000.
Other institutional investors and hedge funds have also bought and sold shares of the company. US Bancorp DE raised its stake in shares of BlackRock Science and Technology Term Trust by 165.3% in the 3rd quarter. US Bancorp DE now owns 1,804 shares of the company’s stock valued at $40,000 after buying an additional 1,124 shares in the last quarter. Geneos Wealth Management Inc. bought a new stake in BlackRock Science and Technology Term Trust in the first quarter valued at about $40,000. Fifth Third Bancorp acquired a new position in BlackRock Science and Technology Term Trust in the first quarter worth about $57,000. Kestra Advisory Services LLC bought a new position in BlackRock Science and Technology Term Trust during the fourth quarter worth about $68,000. Finally, Northwestern Mutual Wealth Management Co. boosted its holdings in BlackRock Science and Technology Term Trust by 13.1% during the second quarter. Northwestern Mutual Wealth Management Co. now owns 6,638 shares of the company’s stock valued at $138,000 after purchasing an additional 767 shares in the last quarter.
BlackRock Science and Technology Term Trust Trading Down 0.1%
Shares of NASDAQ:BSTZ opened at $27.55 on Monday. The business’s fifty day moving average price is $29.41 and its two-hundred day moving average price is $25.35. BlackRock Science and Technology Term Trust has a fifty-two week low of $20.49 and a fifty-two week high of $31.88.
BlackRock Science and Technology Term Trust Announces Dividend
BlackRock Science and Technology Term Trust Company Profile
BlackRock Science and Technology Term Trust (NASDAQ: BSTZ) is a closed-end management investment company that provides targeted exposure to companies engaged in the science and technology sectors. Listed on the NASDAQ stock exchange, the trust seeks to deliver total return composed of capital appreciation and monthly distributions over a defined term. It operates as a term trust, with an anticipated liquidation date in August 2028, at which point shareholders will receive proceeds based on the trust’s net asset value.
The trust’s investment strategy is centered on equity and equity-related securities of companies involved in advancing scientific research, technological innovation and related applications.
See Also
- Five stocks we like better than BlackRock Science and Technology Term Trust
- Strait of Hormuz Tensions Spike Tanker Trade: These 2 Stocks Are Set to Benefit
- Shopify’s Quiet AI Strategy Could Be Its Biggest Advantage Yet
- Why These 3 Nuclear ETFs Are Getting a Fresh Look as AI Power Demand Rises
- 3 Aerospace Suppliers That Could Benefit as Aircraft Makers Face Bottlenecks
Receive News & Ratings for BlackRock Science and Technology Term Trust Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BlackRock Science and Technology Term Trust and related companies with MarketBeat.com's FREE daily email newsletter.
